TY - JOUR AU - Altman, D. PY - 1980 DA - 1980// TI - Statistics and ethics in medical research: III how large a sample? JO - Bmj VL - 281 UR - https://doi.org/10.1136/bmj.281.6251.1336 DO - 10.1136/bmj.281.6251.1336 ID - Altman1980 ER - TY - JOUR AU - Schulz, K. AU - Altman, D. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials JO - BMC Med VL - 8 UR - https://doi.org/10.1186/1741-7015-8-18 DO - 10.1186/1741-7015-8-18 ID - Schulz2010 ER - TY - BOOK PY - 2016 DA - 2016// TI - Guidance for industry: adaptive designs for medical device clinical studies ID - ref3 ER - TY - BOOK PY - 2010 DA - 2010// TI - Draft guidance for industry: adaptive design clinical trials for drugs and biologics ID - ref4 ER - TY - JOUR AU - Mehta, C. AU - Pocock, S. PY - 2011 DA - 2011// TI - Adaptive increase in sample size when interim results are promising: a practical guide with examples JO - Stat Med VL - 30 UR - https://doi.org/10.1002/sim.4102 DO - 10.1002/sim.4102 ID - Mehta2011 ER - TY - STD TI - Chen J, DeMets DL, Lan G. Increasing the sample size when the unblinded interim result is promising. Stat Med. 2004. https://doi.org/10.1002/sim.1688. ID - ref6 ER - TY - JOUR AU - Glimm, E. PY - 2012 DA - 2012// TI - Comments on adaptive increase in sample size when interim results are promising JO - Stat Med VL - 31 UR - https://doi.org/10.1002/sim.4424 DO - 10.1002/sim.4424 ID - Glimm2012 ER - TY - JOUR AU - Gao, P. AU - Ware, J. H. AU - Mehta, C. PY - 2008 DA - 2008// TI - Sample size re-estimation for adaptive sequential design in clinical trials JO - J Biopharm Stat VL - 18 UR - https://doi.org/10.1080/10543400802369053 DO - 10.1080/10543400802369053 ID - Gao2008 ER - TY - JOUR AU - Halpern, S. D. PY - 2005 DA - 2005// TI - Adding nails to the coffin of underpowered trials JO - J Rheumatol VL - 32 ID - Halpern2005 ER - TY - BOOK AU - Mehta, C. R. PY - 2012 DA - 2012// TI - Designs for clinical trials UR - https://doi.org/10.1007/978-1-4614-0140-7 DO - 10.1007/978-1-4614-0140-7 ID - Mehta2012 ER - TY - JOUR AU - Brannath, W. AU - Gutjahr, G. AU - Bauer, P. PY - 2012 DA - 2012// TI - Probabilistic foundation of confirmatory adaptive designs JO - J Am Stat Assoc VL - 107 UR - https://doi.org/10.1080/01621459.2012.682540 DO - 10.1080/01621459.2012.682540 ID - Brannath2012 ER - TY - STD TI - Broberg P. Sample size re-assessment leading to a raised sample size does not inflate type i error rate under mild conditions. BMC Med Res Methodol. 2013;13:94. https://doi.org/10.1186/1471-2288-13-94. ID - ref12 ER - TY - STD TI - Freidlin B, Korn EL. Sample size adjustment designs with time-to-event outcomes: a caution. Clin Trials. 2017. https://doi.org/10.1177/1740774517724746. ID - ref13 ER - TY - JOUR AU - Mehta, C. R. PY - 2013 DA - 2013// TI - Adaptive clinical trial designs with pre-specified rules for modifying the sample size: a different perspective JO - Stat Med VL - 32 UR - https://doi.org/10.1002/sim.5720 DO - 10.1002/sim.5720 ID - Mehta2013 ER - TY - JOUR AU - Pritchett, Y. L. PY - 2015 DA - 2015// TI - Sample size re-estimation designs in confirmatory clinical trials—current state, statistical considerations, and practical guidance JO - Stat Biopharm Res VL - 7 UR - https://doi.org/10.1080/19466315.2015.1098564 DO - 10.1080/19466315.2015.1098564 ID - Pritchett2015 ER - TY - JOUR AU - Posch, M. AU - Bauer, P. PY - 2013 DA - 2013// TI - Adaptive budgets in clinical trials JO - Stat Biopharm Res. VL - 5 UR - https://doi.org/10.1080/19466315.2013.783504 DO - 10.1080/19466315.2013.783504 ID - Posch2013 ER - TY - STD TI - Uozumi R, Hamada C. Adaptive seamless design for establishing pharmacokinetic and efficacy equivalence in developing biosimilars. Ther Innov Regul Sci. 2017. https://doi.org/10.1177/2168479017706526. ID - ref17 ER - TY - JOUR AU - Wang, S. J. AU - James Hung, H. M. AU - O’Neill, R. PY - 2012 DA - 2012// TI - Paradigms for adaptive statistical information designs: practical experiences and strategies JO - Stat Med VL - 31 UR - https://doi.org/10.1002/sim.5410 DO - 10.1002/sim.5410 ID - Wang2012 ER - TY - JOUR AU - Bayar, M. A. AU - Teuff, G. AU - Michiels, S. AU - Sargent, D. J. AU - Deley, M. C. PY - 2016 DA - 2016// TI - New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study JO - Stat Med VL - 35 UR - https://doi.org/10.1002/sim.6942 DO - 10.1002/sim.6942 ID - Bayar2016 ER - TY - JOUR AU - Mehta, C. R. PY - 2016 DA - 2016// TI - Comments on ‘some challenges with statistical inference in adaptive designs’ by Hung, Wang, and Yang JO - J Biopharm Stat VL - 26 UR - https://doi.org/10.1080/10543406.2015.1099541 DO - 10.1080/10543406.2015.1099541 ID - Mehta2016 ER - TY - JOUR AU - Bauer, P. AU - Bretz, F. AU - Dragalin, V. AU - König, F. AU - Wassmer, G. PY - 2016 DA - 2016// TI - Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls JO - Stat Med VL - 35 UR - https://doi.org/10.1002/sim.6472 DO - 10.1002/sim.6472 ID - Bauer2016 ER - TY - JOUR AU - Bowden, J. AU - Mander, A. PY - 2014 DA - 2014// TI - A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials JO - Pharm Stat VL - 13 UR - https://doi.org/10.1002/pst.1613 DO - 10.1002/pst.1613 ID - Bowden2014 ER - TY - JOUR AU - Chen, C. AU - Anderson, K. AU - Mehrotra, D. V. AU - Rubin, E. H. AU - Tse, A. PY - 2018 DA - 2018// TI - A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development JO - Contemp Clin Trials VL - 64 UR - https://doi.org/10.1016/j.cct.2017.09.006 DO - 10.1016/j.cct.2017.09.006 ID - Chen2018 ER - TY - JOUR AU - Tamhane, A. C. AU - Wu, Y. AU - Mehta, C. R. PY - 2012 DA - 2012// TI - Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation JO - Stat Med VL - 31 UR - https://doi.org/10.1002/sim.5377 DO - 10.1002/sim.5377 ID - Tamhane2012 ER - TY - JOUR AU - Bauer, P. AU - Bretz, F. AU - Dragalin, V. AU - König, F. AU - Wassmer, G. PY - 2016 DA - 2016// TI - Authors’ response to comments JO - Stat Med VL - 35 UR - https://doi.org/10.1002/sim.6823 DO - 10.1002/sim.6823 ID - Bauer2016 ER - TY - STD TI - Shih WJ, Li G, Wang Y. Methods for flexible sample-size design in clinical trials: likelihood, weighted, dual test, and promising zone approaches. Contemp Clin Trials. 2016. https://doi.org/10.1016/j.cct.2015.12.007. ID - ref26 ER - TY - JOUR AU - Hung, H. M. J. AU - Wang, S. J. AU - Yang, P. PY - 2014 DA - 2014// TI - Some challenges with statistical inference in adaptive designs JO - J Biopharm Stat VL - 24 UR - https://doi.org/10.1080/10543406.2014.925911 DO - 10.1080/10543406.2014.925911 ID - Hung2014 ER - TY - JOUR AU - Hung, H. M. J. PY - 2016 DA - 2016// TI - Rejoinder to Dr. Cyrus R. Mehta JO - J Biopharm Stat VL - 26 UR - https://doi.org/10.1080/10543406.2015.1099542 DO - 10.1080/10543406.2015.1099542 ID - Hung2016 ER - TY - JOUR AU - Hung, H. M. J. AU - Wang, S. AU - Yang, P. AU - Jin, K. AU - Lawrence, J. PY - 2016 DA - 2016// TI - Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials JO - J Biopharm Stat. VL - 26 UR - https://doi.org/10.1080/10543406.2015.1092025 DO - 10.1080/10543406.2015.1092025 ID - Hung2016 ER - TY - JOUR AU - Turnbull, B. W. PY - 2017 DA - 2017// TI - Adaptive designs from a data safety monitoring board perspective: some controversies and some case studies JO - Clin Trials VL - 14 UR - https://doi.org/10.1177/1740774516689261 DO - 10.1177/1740774516689261 ID - Turnbull2017 ER - TY - STD TI - Jennison C, Turnbull BW. Adaptive sample size modification in clinical trials: start small then ask for more? Stat Med. 2015. https://doi.org/10.1002/sim.6575. ID - ref31 ER - TY - JOUR AU - Liu, Y. AU - Lim, P. PY - 2017 DA - 2017// TI - Sample size increase during a survival trial when interim results are promising JO - Commun Stat Theory Methods VL - 46 UR - https://doi.org/10.1080/03610926.2015.1137596 DO - 10.1080/03610926.2015.1137596 ID - Liu2017 ER - TY - JOUR AU - Levin, G. P. AU - Emerson, S. C. AU - Emerson, S. S. PY - 2013 DA - 2013// TI - Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation JO - Stat Med VL - 32 UR - https://doi.org/10.1002/sim.5662 DO - 10.1002/sim.5662 ID - Levin2013 ER - TY - JOUR AU - Gaffney, M. AU - Ware, J. H. PY - 2017 DA - 2017// TI - An evaluation of increasing sample size based on conditional power JO - J Biopharm Stat VL - 27 UR - https://doi.org/10.1080/10543406.2017.1289943 DO - 10.1080/10543406.2017.1289943 ID - Gaffney2017 ER - TY - JOUR AU - Maca, J. AU - Dragalin, V. AU - Gallo, P. PY - 2014 DA - 2014// TI - Adaptive clinical trials: overview of phase III designs and challenges JO - Ther Innov Regul Sci VL - 48 UR - https://doi.org/10.1177/2168479013507436 DO - 10.1177/2168479013507436 ID - Maca2014 ER - TY - JOUR AU - Hampson, L. V. AU - Jennison, C. PY - 2012 DA - 2012// TI - Group sequential tests for delayed responses (with discussion) JO - J R Stat Soc B VL - 75 UR - https://doi.org/10.1111/j.1467-9868.2012.01030.x DO - 10.1111/j.1467-9868.2012.01030.x ID - Hampson2012 ER - TY - JOUR AU - Chen, J. AU - Yuan, S. AU - Li, X. PY - 2018 DA - 2018// TI - Statistical inference following sample size adjustment based on the 50%-conditional-power principle JO - J Biopharm Stat VL - 28 UR - https://doi.org/10.1080/10543406.2017.1372766 DO - 10.1080/10543406.2017.1372766 ID - Chen2018 ER - TY - STD TI - Antonijevic Z. The impact of adaptive design on portfolio optimization. Ther Innov Regul Sci. 2016. https://doi.org/10.1177/2168479016640020. ID - ref38 ER - TY - STD TI - Liu L, Hsiao S, Mehta CR. Efficiency considerations for group sequential designs with adaptive unblinded sample size re-assessment. Stat Biosci. 2017:1–15. https://doi.org/10.1007/s12561-017-9188-x. ID - ref39 ER - TY - JOUR AU - Wang, S. -. J. AU - Brannath, W. AU - Brückner, M. AU - James Hung, H. M. AU - Koch, A. PY - 2013 DA - 2013// TI - Unblinded adaptive statistical information design based on clinical endpoint or biomarker JO - Stat Biopharm Res VL - 5 UR - https://doi.org/10.1080/19466315.2013.791639 DO - 10.1080/19466315.2013.791639 ID - Wang2013 ER - TY - JOUR AU - Li, G. AU - Shih, W. J. AU - Xie, T. AU - Lu, J. PY - 2002 DA - 2002// TI - A sample size adjustment procedure for clinical trials based on conditional power JO - Biostatistics VL - 3 UR - https://doi.org/10.1093/biostatistics/3.2.277 DO - 10.1093/biostatistics/3.2.277 ID - Li2002 ER -